{"url_path":"/sec/abeo/8-k/2026-06-10/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/318306/0001493152-26-028106-index.html","accession_number":"0001493152-26-028106","cik":"0000318306","ticker":"ABEO","issuer_name":"ABEONA THERAPEUTICS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/318306/0001493152-26-028106-index.html","primary_entity_key":"0000318306","primary_entity_name":"ABEONA THERAPEUTICS INC."},"word_count":85,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n**(d)\nExhibits.**\n\n** **\n\n**Exhibit\nNo.**\n \n**Description**\n\n \n \n \n\n99.1\n \n[Abeona Therapeutics Inc. Presentation, dated June 10, 2026, entitled “Investor Presentation”](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \nAbeona\nTherapeutics Inc.\n\n \n(Registrant)\n\n \n \n \n\n \nBy:\n*/s/\nJoseph Vazzano*\n\n \nName:\nJoseph\nVazzano\n\n \nTitle:\n\nChief\nFinancial Officer\n\n \n\nDate:\nJune 10, 2026"}